TipRanks
California Nanotechnologies Corp (TSE:CNO)
:CNO
Canadian Market
Want to see TSE:CNO full AI Analyst Report?

California Nanotechnologies (CNO) AI Stock Analysis

28 Followers

Top Page

TSE:CNO

California Nanotechnologies

(CNO)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - Gpt-5.6Sol)
Rating:47Neutral
Price Target:
C$0.39
▲(24.84% Upside)
Action:Reiterated
Date:09/17/26
The score is held down primarily by weak financial performance: sharply negative profitability and renewed cash burn outweigh modest revenue growth, even though leverage appears moderate. Technicals are a partial offset with strong trend signals (price above major moving averages and positive MACD), but extremely overbought RSI/Stoch adds near-term risk. Valuation is also constrained by losses (negative P/E) and no provided dividend yield.
Positive Factors
Specialized advanced-materials platform
CNO combines engineered powder sales with specialized processing services for customers requiring controlled particle size, composition, and microstructure. This technical focus supports differentiated applications in additive and powder-based manufacturing and provides more than one route to recurring customer work.
Negative Factors
Deeply negative profitability
CNO is currently unable to convert positive gross profit and roughly 7% revenue growth into sustainable operating or net earnings. Deeply negative margins weaken internal funding capacity and indicate that cost structure or pricing power must improve before growth can translate into durable shareholder value.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialized advanced-materials platform
CNO combines engineered powder sales with specialized processing services for customers requiring controlled particle size, composition, and microstructure. This technical focus supports differentiated applications in additive and powder-based manufacturing and provides more than one route to recurring customer work.
Read all positive factors

California Nanotechnologies (CNO) vs. iShares MSCI Canada ETF (EWC)

California Nanotechnologies Business Overview & Revenue Model

Company Description
California Nanotechnologies Corp. is dedicated to the research, advancement, and manufacturing of nanocrystalline materials, primarily achieved through the reduction of grain size. The company offers a comprehensive array of advanced material proc...
How the Company Makes Money
CNO makes money primarily by selling materials and charging for processing/manufacturing services associated with producing and refining advanced metal/alloy powders. Key revenue streams include: (1) materials sales—revenue from supplying nanostru...

California Nanotechnologies Financial Statement Overview

Summary
Despite ~7% TTM revenue growth, profitability has deteriorated sharply with deeply negative EBIT/EBITDA and heavily negative net margins. Cash flow is also weak with negative operating and free cash flow (cash burn). The balance sheet is improved with moderate leverage (debt-to-equity ~0.66) and positive equity, but strongly negative returns and ongoing losses elevate risk if the downturn persists.
Income Statement
24
Negative
Balance Sheet
47
Neutral
Cash Flow
28
Negative
BreakdownMay 2026May 2025May 2024May 2022May 2021
Income Statement
Total Revenue2.83M6.22M3.34M1.82M1.06M
Gross Profit-610.56K4.59M2.33M669.57K439.97K
EBITDA-1.32M780.97K753.02K337.91K10.77K
Net Income-1.89M-158.33K381.68K79.76K-161.40K
Balance Sheet
Total Assets3.88M5.50M2.36M1.41M587.40K
Cash, Cash Equivalents and Short-Term Investments207.00K533.85K841.35K294.13K25.29K
Total Debt1.31M1.62M1.21M1.94M1.94M
Total Liabilities1.90M3.19M2.21M2.70M2.24M
Stockholders Equity1.98M2.32M145.97K-1.29M-1.66M
Cash Flow
Free Cash Flow-439.56K797.00K89.98K604.26K33.20K
Operating Cash Flow-388.46K2.92M104.28K717.01K33.20K
Investing Cash Flow-51.11K-2.11M-14.30K-112.75K0.00
Financing Cash Flow107.53K-1.12M535.33K-387.83K-62.52K

California Nanotechnologies Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.31
Price Trends
50DMA
0.34
Positive
100DMA
0.31
Positive
200DMA
0.31
Positive
Market Momentum
MACD
0.02
Positive
RSI
53.47
Neutral
STOCH
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CNO, the sentiment is Positive. The current price of 0.31 is below the 20-day moving average (MA) of 0.39, below the 50-day MA of 0.34, and above the 200-day MA of 0.31, indicating a neutral trend. The MACD of 0.02 indicates Positive momentum. The RSI at 53.47 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:CNO.

California Nanotechnologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
57
Neutral
C$189.38M-22.37-5.06%2.01%6.10%-46.82%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
47
Neutral
C$18.38M-7.19-76.50%―-42.97%-34.24%
47
Neutral
C$104.21M-6.19-81.75%――-42.93%
47
Neutral
C$309.01M-10.91-969.63%―224.03%-204.33%
41
Neutral
C$6.09M-6.09-24.00%――-904.55%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CNO
California Nanotechnologies
0.39
-0.11
-21.40%
TSE:BOS
Airboss of America
6.97
1.89
37.31%
TSE:NANO
Nano One Materials
0.87
-0.73
-45.63%
TSE:GMG
Graphene Manufacturing Group Ltd
2.31
1.54
200.00%
TSE:SURE
SureNano Science Ltd
0.15
0.03
31.82%

California Nanotechnologies Corporate Events

Business Operations and StrategyFinancial Disclosures
Cal Nano Secures Development Deal and $2 Million in Recent Orders
Positive
Sep 16, 2026
California Nanotechnologies Corp., a Los Angeles-area materials science specialist, processes metallurgical powders into advanced components using Spark Plasma Sintering and other technologies. Operating two manufacturing facilities, it supports F...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 17, 2026